Fundz

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer

PRIVATEAug 14, 2026

Position

Chief Financial Officer

Company

Olema Oncology

Jason O’Byrne
United StatesBiotechnologyHealth CareTherapeutics

Description

Olema Oncology has announced the appointment of Jason O’Byrne as chief financial officer. His extensive expertise will be crucial as the company approaches pivotal data and prepares for its first potential commercial launch.

Quick answer

Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer (August 14, 2026). Olema Oncology is based in United States.

Who is the new Chief Financial Officer at Olema Oncology?
Olema Oncology named Jason O’Byrne Chief Financial Officer, announced August 14, 2026.
What did Olema Oncology announce on August 14, 2026?
Olema Oncology has announced the appointment of Jason O’Byrne as chief financial officer. His extensive expertise will be crucial as the company approaches pivotal data and prepares for its first potential commercial launch.
What does Olema Oncology do?
Olema Oncology is a US clinical-stage biotech company focused on developing targeted therapies for cancer.
Where is Olema Oncology based?
Olema Oncology is based in United States.
Which similar companies made leadership changes around the same time?
Neumora (August 14, 2026), Olema Oncology, Inc. (August 13, 2026), EIT Pharma (August 12, 2026) and Kalohexis (August 11, 2026) also announced leadership changes within 45 days of Olema Oncology.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Olema Oncology, and when

A new leader at Olema Oncology brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Olema Oncology raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Olema Oncology, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Olema Oncology. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Olema Oncology

Location

United States

About

Olema Oncology is a US clinical-stage biotech company focused on developing targeted therapies for cancer. The company is dedicated to advancing innovative solutions that address unmet medical needs in oncology. Olema's mission is to transform the lives of patients with cancer through its groundbreaking treatments.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Olema Oncology changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Olema Oncology's next move

Learn about Strategic plan

Olema Oncology changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.